Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brand-Generic "Pay-For-Delay" Settlements Jump 63% In FY 2010

This article was originally published in The Pink Sheet Daily

Executive Summary

As a proportion of total settlements reported to FTC, however, the ones involving compensation to the generic firm remained the same.
Advertisement

Related Content

FTC Rushes Patent Settlement Report In Push For Super Committee Action On "Pay-For-Delay"
FTC Rushes Patent Settlement Report In Push For Super Committee Action On "Pay-For-Delay"
Authorized Generics Do Not Deter Patent Challenges, FTC Says, But May Be Used To Delay Competition
Authorized Generics Do Not Deter Patent Challenges, FTC Says, But May Be Used To Delay Competition
PCMA Makes Specific Rx Cost-Cutting Proposals To Congressional "Super Committee"
European Commission Drops Boehringer Case And Lauds Itself For Receding Patent Abuse
FTC Letters On Ambien CR Agreements Are "Educational" And A "Warning" For Industry
Lipitor Generics Problem Illustrates Need For Hatch-Waxman Reform, Academics Say
Lipitor Generics Problem Illustrates Need For Hatch-Waxman Reform, Academics Say
Cephalon Loses Bid To Get FTC Documents On Brand-Generic Reverse Settlements

Topics

Advertisement
UsernamePublicRestriction

Register

PS072302

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel